Navigation Links
Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance
Date:10/31/2007

r the comparable period of 2006. The ratio of cost of sales to net sales was stable year-on-year, with the impact of generic competition for Ambien(R) IR partly offset by a better product mix. Other revenues, at euro 845 million, were down on the 2006 9-month figure (euro 888 million), due largely to the discontinuation of royalty income on fipronil.

Research and development expenses rose by 1.5% (4.4% excluding the effect of exchange rates).

Over the first nine months of 2007, the cost adaptation measures initiated in 2006 helped to reduce the ratio of selling and general expenses to net sales to 26.3%, 1.6 points lower than in the comparable period of 2006. Selling and general expenses for the nine-month period were euro 5,558 million, a reduction of 5.3%, with selling expenses and general expenses falling in equal proportions.

Other current operating income (net of expenses) totaled euro 200 million, versus euro 236 million in the comparable period of 2006, and included an expense of euro 61 million (euro 42 million after tax) on the harmonization of welfare and healthcare plans for the Group's retirees.

Operating income -- current rose by 4.1%, and represented 36.2% of net sales compared with 35.0% in the first nine months of 2006.

A restructuring charge of euro 50 million (euro 35 million after tax) has been recognized in connection with the ongoing adaptation plan initiated in France in 2006.

In the comparable period of 2006, the financial statements included gains on disposal of euro 553 million, mainly on the sale of the Exubera(R) rights (euro 460 million, or euro 384 million after tax) and the sale of the residual stake in the Animal Nutrition business (euro 45 million, or euro 31 million after tax).

Net financial expense was euro 111 million, against euro 146 million in the comparable period of 2006. Interest expense on debt was euro 176 million, compared with euro 250 million in the nine months to end September 2
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
2. Sanofi-Aventis sets the ball rolling for trials of H7N1 bird flu vaccine
3. Sanofi-Aventis Allows Thais To Make Plavix
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... and Montreal, Canada (PRWEB) May 30, 2015 ... process control, and quality assurance, is joining forces with ... offline inspection solutions to the worldwide printing market. ... AVT with a new software engine for its offline ... needs of the printing industry and its varying production ...
(Date:5/30/2015)... NC (PRWEB) May 30, 2015 The ... that crocidolite asbestos has a high potential to cause ... the full story now on the Surviving Mesothelioma ... Institute of Occupational Medicine in Lodz, Poland found that, ... asbestos workers between 1970 and 2012, all of them ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 EHO offers ... Web Portal that gives hospices the ability to manage ... Because of this business model, EHO has been able ... pricing to its clients and survive among the giants ... hospice management systems three years ago, it has simplified ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Cyclist ... tour, “Wheels for the World 2015: Piles of ... to raise awareness about hemophilia and encourage individuals ... Life. , Save One Life supports nearly ... eleven developing countries through direct sponsorships, scholarships and ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 This year ... partners with Pulmonary Horizons to offer one of the ... identify and discuss successful practices to diagnose, treat and ... the Pulmonary Horizons Conference is Interaction with ... address the Overall Needs of Patients with COPD," said ...
Breaking Medicine News(10 mins):Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 2Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 3Health News:New Study Finds Close Link Between Crocidolite Asbestos and Deadly Mesothelioma, According to Surviving Mesothelioma 2Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 3
... Diabetes mellitus is an independent risk factor for cardiovascular ... risk by 2-6 fold relative to nondiabetic subjects and ... mellitus patients will die of an atherosclerotic event. In ... cardiovascular disease, and so the presence of even borderline-high-risk ...
... and his colleagues from Southampton University have found a new ... of two or more genes fuse. The research team is ... common form of childhood leukemia, which is called as Acute ... to develop this genetic test. The treatment is given by ...
... Alzheimer’s disease (AD) is one of the most common forms ... the parts of the brain that control thought, memory, and ... an association between AD risk and several vitamins and have ... that total intake of folate at or above the RDA ...
... been demonstrated that our own experience is important to exhibit ... have been working hard to understand what happens in our ... action. The results of the observation show that the actions ... , ,The research points out that we understand the ...
... and vegetables can pave way for a long and healthy ... out that fruits and vegetables can cause dangerous interactions when ... the activity and toxicity of orally administered drugs. The effect ... ,One of the most studied or well documented of these ...
... approximately one in every 1,000 children and is characterized ... factors have been as causative factors for the disorder. ... the age of 16. There is no satisfactory treatment ... symptoms significantly. , ,The five most common types ...
Cached Medicine News:Health News:Feelings Of Sympathy And Empathy Dictated by Personal Experience 2Health News:Feelings Of Sympathy And Empathy Dictated by Personal Experience 3Health News:Guidelines for treatment of juvenile idiopathic arthritis formulated 2
(Date:5/29/2015)... , May 29, 2015  Eli Lilly and Company ... ) today announced that they have entered into a ... efficacy of AstraZeneca,s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, ... Receptor 2 antiangiogenic cancer medicine. The planned study will ... advanced solid tumors. The Phase I study ...
(Date:5/29/2015)... 2015 Educating the community continues to ... the Advancement of Wound Care (AAWC), which was ... AAWC,s corporate partners, the Association provides medical professionals ... AAWC website at http://aawconline.org/education-for-the-generalist/ . The portal ... links to various CME/CEU educational programs. This education ...
(Date:5/28/2015)... and HOUSTON , May 28, ... (TSX-V: EPI) today reported financial results for the second quarter ... unless specified otherwise, are expressed in Canadian dollars and in ... Summary Results ESSA recorded a net loss ... months ended March 31, 2015 (Q2-2015), compared to a net ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14The Association for the Advancement of Wound Care Educates the Public 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... 2012 Allscripts (NASDAQ: MDRX) today announced that ... ™ to manage the revenue cycle for 39 affiliated providers ... integrated Allscripts Electronic Health Record (EHR) to automate ... the insights they need to deliver superior patient care. ...
... SAN FRANCISCO, Jan. 4, 2012  Practice Fusion, the ... community in the US, announced today that its ... a faster, simpler and more streamlined user experience ... technology flagged more than 7,000 deadly drug interactions ...
Cached Medicine Technology:Mammoth Hospital Selects Allscripts RCM Services 2Mammoth Hospital Selects Allscripts RCM Services 3Mammoth Hospital Selects Allscripts RCM Services 4Mammoth Hospital Selects Allscripts RCM Services 5Practice Fusion's Top-Rated e-Prescribing Software Gets a Doctor-Driven Makeover 2Practice Fusion's Top-Rated e-Prescribing Software Gets a Doctor-Driven Makeover 3
... The patented ratchet design provides fingertip ... ,The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ...
... A broad selection of procedurally ... capability and allow easy access to ... a variety of approaches.,Loop Handled Graspers ... that holds tissue firmly without tearing ...
... selection of procedurally specific tip configurations ... easy access to all areas of ... approaches.,Loop Handled Graspers feature an "infinite ... firmly without tearing or slipping ...
...
Medicine Products: